BEN vs CCCC · P/E 36, rev $8.77B vs rev $35.6M
Franklin Resources Inc (BEN) versus C4 Therapeutics Inc (CCCC) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. CCCC currently screens at market cap $425.7M.
Not investment advice. Open the BEN and CCCC stock pages for the full models.
Not investment advice.